Seeking Alpha

Clovis Oncology falls after pricing stockholder offering at discount

  • Clovis Oncology (CLVS) announces the pricing of a 2M share public offering by selling stockholders.
  • The price to the public is $57.50, a 2.4% discount to Tuesday's close.
  • CLVS -1.6% premarket. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio: